Status:

RECRUITING

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Lead Sponsor:

Medtronic

Conditions:

Arrhythmia

Bradycardia

Eligibility:

All Genders

Brief Summary

The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzi...

Detailed Description

All Medtronic market-released leads and all market-released IPG, ICD and CRT devices are eligible to be included in this study.

Eligibility Criteria

Inclusion

  • Subjects who meet the following inclusion criteria and do not meet any of the following exclusion criteria are eligible for enrollment.
  • • Subject or appropriate legal guardians provide written informed consent and/or authorization for access to and use of health information as required by an institution's IRB/MEC/REB
  • AND one of the following must also apply:
  • Subject is indicated for implant or within 30 days post-implant of at least one Medtronic market-released product used for a pacing, sensing or defibrillation application
  • Subjects who participated in a qualifying study (IDE) of a Medtronic market-released product with complete implant and follow-up data and subject or appropriate legal guardian authorizes release of subject study data

Exclusion

  • Subjects who are, or will be inaccessible for follow-up
  • Subjects with exclusion criteria required by local law (EMEA only)
  • Subjects receiving an implant of a Medtronic device at a non-participating center and the implant data and current status cannot be confirmed within 30 days after implant
  • Subjects implanted with a Medtronic device whose predetermined enrollment limit for that specific product has been exceeded

Key Trial Info

Start Date :

January 1 1983

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2040

Estimated Enrollment :

20000 Patients enrolled

Trial Details

Trial ID

NCT00271180

Start Date

January 1 1983

End Date

December 1 2040

Last Update

December 17 2025

Active Locations (318)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 80 (318 locations)

1

Birmingham, Alabama, United States

2

Anchorage, Alaska, United States

3

Chandler, Arizona, United States

4

Jonesboro, Arkansas, United States